These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714 [TBL] [Abstract][Full Text] [Related]
29. Risk of colorectal cancer in ulcerative colitis in India. Venkataraman S; Mohan V; Ramakrishna BS; Peter S; Chacko A; Chandy G; Kurian G; Kurian S; Mathan M; Mathan VI; Patra S; Pulimood A; Rolston DD J Gastroenterol Hepatol; 2005 May; 20(5):705-9. PubMed ID: 15853982 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Florin TH; Pandeya N; Radford-Smith GL Gut; 2004 Jul; 53(7):973-9. PubMed ID: 15194646 [TBL] [Abstract][Full Text] [Related]
31. Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. Lashner BA; Provencher KS; Bozdech JM; Brzezinski A Am J Gastroenterol; 1995 Mar; 90(3):377-80. PubMed ID: 7872273 [TBL] [Abstract][Full Text] [Related]
32. Restorative proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis after liver transplant for primary sclerosing cholangitis: case report and review of literature. Grucela AL; Steinhagen RM Am Surg; 2005 Apr; 71(4):362-5. PubMed ID: 15943415 [TBL] [Abstract][Full Text] [Related]
33. Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan. Fujita T; Ando T; Watanabe O; Hasegawa M; Miyake N; Kondo S; Kato T; Ishiguro K; Nakamura M; Miyahara R; Ohmiya N; Niwa Y; Goto H Hepatogastroenterology; 2010; 57(99-100):487-92. PubMed ID: 20698214 [TBL] [Abstract][Full Text] [Related]
34. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Jensen AB; Larsen M; Gislum M; Skriver MV; Jepsen P; Nørgaard B; Sørensen HT Am J Gastroenterol; 2006 Jun; 101(6):1283-7. PubMed ID: 16771950 [TBL] [Abstract][Full Text] [Related]
35. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA; Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827 [TBL] [Abstract][Full Text] [Related]
36. High lifetime risk of cancer in primary sclerosing cholangitis. Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma. Brüwer M; Schmid KW; Senninger N; Schürmann G World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079 [TBL] [Abstract][Full Text] [Related]
40. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Loftus EV Gastroenterol Clin North Am; 2006 Sep; 35(3):517-31. PubMed ID: 16952738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]